Results of phase 3 will be out by June 25th-July 9th as per the last conference call.
FDA Fast Track with QIDP designation and patent protection until June 2024. Formulation patent protection until November 2036.
Being the only player in the game. This has huge upside potential especially once they have the manufacture in place and the product is in production we should see massive amounts of cash flow.
Submitted June 21, 2021 at 10:48PM by stockmaste4r https://ift.tt/3qghMRi
